Belgium · Delayed Price · Currency is EUR Hyloris Pharmaceuticals Statistics
Total Valuation
EBR:HYL has a market cap or net worth of EUR 137.76 million. The enterprise value is 125.60 million.
| Market Cap | 137.76M |
| Enterprise Value | 125.60M |
Important Dates
The next confirmed earnings date is Thursday, September 24, 2026.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBR:HYL has 28.00 million shares outstanding.
| Current Share Class | 28.00M |
| Shares Outstanding | 28.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +4.78% |
| Owned by Insiders (%) | 58.91% |
| Owned by Institutions (%) | 0.00% |
| Float | 11.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.35 |
| PB Ratio | 5.20 |
| P/TBV Ratio | 5.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.89 |
| Quick Ratio | 3.76 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.23 |
| Interest Coverage | -121.58 |
Financial Efficiency
Return on equity (ROE) is -21.61% and return on invested capital (ROIC) is -16.41%.
| Return on Equity (ROE) | -21.61% |
| Return on Assets (ROA) | -13.63% |
| Return on Invested Capital (ROIC) | -16.41% |
| Return on Capital Employed (ROCE) | -28.86% |
| Weighted Average Cost of Capital (WACC) | 7.74% |
| Revenue Per Employee | 144,345 |
| Profits Per Employee | -115,164 |
| Employee Count | 55 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -374,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.08% in the last 52 weeks. The beta is 0.64, so EBR:HYL's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -19.08% |
| 50-Day Moving Average | 5.17 |
| 200-Day Moving Average | 6.10 |
| Relative Strength Index (RSI) | 39.04 |
| Average Volume (20 Days) | 3,439 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EBR:HYL had revenue of EUR 7.94 million and -6.33 million in losses. Loss per share was -0.23.
| Revenue | 7.94M |
| Gross Profit | 7.56M |
| Operating Income | -8.15M |
| Pretax Income | -6.71M |
| Net Income | -6.33M |
| EBITDA | -8.03M |
| EBIT | -8.15M |
| Loss Per Share | -0.23 |
Balance Sheet
The company has 13.78 million in cash and 1.61 million in debt, with a net cash position of 12.17 million or 0.43 per share.
| Cash & Cash Equivalents | 13.78M |
| Total Debt | 1.61M |
| Net Cash | 12.17M |
| Net Cash Per Share | 0.43 |
| Equity (Book Value) | 26.48M |
| Book Value Per Share | 0.95 |
| Working Capital | 14.83M |
Cash Flow
In the last 12 months, operating cash flow was -6.99 million and capital expenditures -4,000, giving a free cash flow of -6.99 million.
| Operating Cash Flow | -6.99M |
| Capital Expenditures | -4,000 |
| Depreciation & Amortization | 118,000 |
| Net Borrowing | -339,000 |
| Free Cash Flow | -6.99M |
| FCF Per Share | -0.25 |
Margins
Gross margin is 95.23%, with operating and profit margins of -102.61% and -79.78%.
| Gross Margin | 95.23% |
| Operating Margin | -102.61% |
| Pretax Margin | -84.49% |
| Profit Margin | -79.78% |
| EBITDA Margin | -101.12% |
| EBIT Margin | -102.61% |
| FCF Margin | n/a |
Dividends & Yields
EBR:HYL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.60% |
| FCF Yield | -5.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for EBR:HYL is 13.57, which is 181.54% higher than the current price. The consensus rating is "Buy".
| Price Target | 13.57 |
| Price Target Difference | 181.54% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 177.74% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBR:HYL has an Altman Z-Score of 10.68 and a Piotroski F-Score of 2.
| Altman Z-Score | 10.68 |
| Piotroski F-Score | 2 |